Ascletis Pharma Inc. operates as a biotechnology company. The Company develops and discovers anti-viral drugs to address unmet medical needs in anti-viral, cancer, and fatty liver disease. Ascletis Pharma offers its services worldwide.
Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team.Ā Ā This week we update on Softbank Group (9984...
Innovent Biologics was priced at theĀ highĀ end and itĀ started trading yesterday (November 1st). It traded up by 18.5% on the first day and 8% on the...